TrialSpark, Inc is a tech-driven pharma company based in New York, NY, dedicated to revolutionizing drug development and bringing new treatments to patients faster and more efficiently. With a focus on radical efficiency and proprietary technology advancements, TrialSpark acquires clinical-stage drugs and leverages their tech-driven platform to accelerate the development process, bridging the gap between scientific discovery and patient access.
Formation Bio, a subsidiary of TrialSpark, Inc, is a leading player in the future of pharma, striving to meet critical unmet patient needs by developing treatments faster than ever before. By acquiring clinical-stage drugs and leveraging their proprietary tech-driven drug development platform, Formation Bio aims to reach inflection points earlier than industry norms, accelerating access to potential new treatments for patients while maximizing value per drug program.
Generated from the website